Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: An in-vitro study in human neuronal and immune cells

Journal of Psychopharmacology

Volumn 24, Issue 12, 2010, Pages 1829-1833

  Schmidt, A J ^a   Krieg, J C ^a   Clement, H W ^b   Gebhardt, S ^a   Schulz, E ^b   Heiser, P ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

atomoxetine; ATP; cells; psychostimulants; survival

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CELL LINE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY METABOLISM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; NERVE CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; CELL LINE, TUMOR; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HUMANS; METHYLPHENIDATE; MONOCYTES; NEUROBLASTOMA; PROPYLAMINES; U937 CELLS;

EID: 78650110238     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109105563     Document Type: Article

References (26)

1. Andreazza, AC, Frey, BN, Valvassori, SS, Zanotto, C., Gomes, KM, Comim, CM, et al. (2007) DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 31: 1282-1288.
2. Biederman, J. (2003) Pharmacotherapy for attention-deficit/ hyperactivity disorder (ADHD) decrease the risk for substance abuse: findings from a longitudinal follow-up youths with and without ADHD. J Clin Psychiatry 64 (Suppl. 11). 3-8.
3. Buitelaar, JK, Danckaerts, M., Gillberg, C., Zuddas, A., Becker, K., Bouvard, M., et al. (2004) A prospective, multicenter, open-label assesment of atomoxetine in non-North American children and adolsecents with ADHD. Eur Child Adolesc Psychiatry 13: 249-257.
4. Castellanos, FX, Lee, PP, Sharp, W., Jeffries, NO, Greenstein, DK, Clasen, LS, et al. (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288: 1740-1748.
5. Chan, P., Di Monte, DA, Luo, JJ, DeLanney, LE, Irwin, I., Langston, JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62: 2484-2487.
6. Fagundes, AO, Rezin, GT, Zanette, F., Grandi, E., Assis, LC, Dal-Pizzol, F., et al. (2007) Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. Int J Dev Neurosci 25: 47-51.
7. Fleming, SM, Delville, Y., Schallert, T. (2005) An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's diesease: antiparkinson effects of sineset and protective effects of methylphenidate. Behav Brain Res 156: 201-213.
8. Frey, BN, Martins, MR, Petronilho, FC, Dal-Pizzol, F., Quevedo, J., Kapczinski, F. (2006 a) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8: 275-280.
9. Frey, BN, Valvassori, SS, Gomes, KM, Martins, MR, Dal-Pizzol, F., Kapczinski, F., et al. (2006 b) Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res 1097: 224-229. (Pubitemid 44041287)
10. Frey, BN, Valvassori, SS, Reus, GZ, Martins, MR, Petronilho, FC, Bardini, K., et al. (2006 c) Changes in antioxidant defense enzymes after D-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31: 699-703.
11. Gomes, KM, Petronilho, FC, Mantovani, M., Garbelotto, T., Boeck, CM, Dal-Pizzol, F., et al. (2008) Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res 33: 1024-1027.
12. Hubert, GW, Jones, DC, Moffett, MC, Rogge, G., Kuhar, MJ (2008) CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol 75: 57-62.
13. Jeng, W., Wong, AW Ting-A-Kee, R., Wells, PG (2005) Methamphetamine- enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 39: 317-326.
14. Klöcking, R., Schacke, M., Wutzler, P. (1995) Primärscreening antiherpetischer Verbindungen mit EZ4U. Chemotherapie J 4: 141-147.
15. Ludolph, AG, Schaz, U., Storch, A., Liebau, S., Fegert, JM, Boeckers, TM (2006) Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro. J Neural Transm 113: 1927-1934.
16. Mao, P., Ardeshiri, A., Jacks, R., Yang, S., Hurn, PD, Alkayed, NJ (2007) Mitochondrial mechanism of neuroprotection by CART. Eur J Neurosci 26: 624-632.
17. Martins, MR, Reinke, A., Petronilho, FC, Gomes, KM, Dal-Pizzol, F., Quevedo, J. (2006) Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 1078: 189-197.
18. Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, FR, et al.; Atomoxetine ADHD Study Group (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108: E83.
19. Pliszka, SR, Lancester, J., Liotti, M., Semrud-Clikeman, M. (2006) Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD. Neurology 67: 1023-1027.
20. Reneman, L., De Bruin, K., Lavalaye, J., Gunning, WB, Booij, J. (2001) Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [1231]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse 39: 193-200.
21. Rogge, G., Jones, D., Hubert, GW, Lin, Y., Kuhar, MJ (2008) CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 9: 747-758.
22. Stopper, H., Walitza, S., Warnke, A., Gerlach, M. (2008) Brief review of available evidence concerning the potential induction of genomic damage. J Neural Transm 115: 331-334.
23. Swanson, JM, Sergeant, JA, Taylor, E., Sonega-Barke, EJ, Jensen, PS, Cantwell, DP (1998) Attention-defecit hyperactivity disorder and hyperkinetic disorder. Lancet 351: 429-433.
24. Teo, SK, Stirling, DI, Thomas, SD, Hoberman, AM, Christian, MS, Khetani, VD (2002) The perinatal and postnatal toxicity of D-methylphenidate and D, L-methylphenidate in rats. Reprod Toxicol 16: 353-366.
25. Wu, B., Hu, S., Yang, M., Pan, H., Zhu, S. (2006) CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor. Biochem Biophys Res Commun 347: 656-661.
26. Yuan, J., McCann, U., Ricaurte, G. (1997) Methylphenidate and brain dopamine neurotoxicity. Brain Res 767: 172-175.